ATP-competitive DNA gyrase and topoisomerase IV inhibitors as antibacterial agents
{{output}}
Introduction: The bacterial topoisomerases DNA gyrase and topoisomerase IV are validated targets for development of novel antibacterial agents. Fluoroquinolones inhibit the catalytic GyrA and/or ParC(GrlA) subunit and have been c... ...
